CA-VISA-INC.
Visa Inc. (NYSE: V) today announced Visa Smarter Stand-in Processing (Smarter STIP), a new capability that uses real-time artificial intelligence (AI) to help financial institutions manage transaction authorizations when service disruptions occur. Using deep learning to analyze past transactions, Smarter STIP generates informed decisions to approve or decline transactions on behalf of issuers in the event that their systems go offline. Visa pioneered the use of AI and neural networks to prevent fraud—Smarter STIP builds on that track record, and is the first in a suite of new AI-powered innovations coming to VisaNet, Visa’s global processing network.
“Consumers expect instant and uninterrupted access to their funds—failure to meet that expectation can be costly,” says Jack Forestell, executive vice president and chief product officer, Visa. “Stand-in processing has always been a vital assurance to our clients that when the unexpected occurs, we’ve got their back. By adding AI, that capability becomes smarter, stronger, and more dynamic.”
Addressing the challenge of downtime
Whether it’s scheduled maintenance or an unexpected outage, service downtime is disruptive for financial institutions and their customers. When stand-in processing is not in place, the potential impacts can be profound: lost revenue due to failed transactions, poor cardholder experience resulting in call volume spikes to customer service centers, damage to reputation, and even scrutiny from regulators.
Visa’s new Smarter STIP service builds on Visa’s existing STIP capability by using deep learning to analyze past transactions down to the cardholder level. Thus the transaction decision that Smarter STIP provides is based on unique insights derived from the cardholder’s past purchasing behavior, rather than solely on static rules applied across an entire card portfolio. With this added intelligence, Visa is able to provide a transaction decision on the issuer’s behalf that more closely mirrors the issuer’s own decision making process—with the potential to decrease transaction declines for cardholders by up to 50% in some cases.1
Harnessing AI for the Payments Ecosystem
Visa Smarter STIP is one of several new real-time deep learning capabilities designed to solve long-standing challenges and pain points for buyers, sellers, and financial institutions.
These enhanced services are made possible by the investments Visa has made to optimize its core infrastructure. This includes a scalable, high-performing, GPU-based platform designed to support the rapid deployment of deep learning capabilities.
“AI is one of the most transformative technologies of our time, giving us the power to build data-driven products that deliver new levels of insight and personalization. With one of the largest and richest data sets in the world, Visa is extremely well positioned to unlock the full potential of AI for our clients and cardholders, and at massive scale,” says Rajat Taneja, president of technology at Visa. “We’ve made significant investments in our infrastructure, making it possible to harness this data more deeply across all facets of VisaNet. Our data, combined with low-latency architecture and our unique modeling capabilities, make our technology platform among the most powerful for AI.”
Global adoption already underway
Smarter STIP will be available in October 2020 and has generated interest from a range of financial institutions around the world.
“At UBS, we believe in building a better future for our customers by harnessing the power of innovation and collaboration—a continuous process that relies on innovative thinking and transformative technologies and capabilities, developed both in-house and by our partners,” says Stefan Uebelhart, Head of UBS Card Center. “We are very pleased to launch Visa’s Smarter STIP service, as this is an example where the power of collaboration, transformative technologies and innovation come together to provide an improved experience for our cardholders. In our quest to build a better future for our customers, we see Visa as a valued partner and intend to work together in the innovation space.”
“As a leader in interest-free shopping platforms in Australia and New Zealand, Latitude Financial is constantly exploring new technology and innovation so we can deliver the best possible service to our customers,” said Latitude’s Chief Commercial Officer, Paul Varro. “Visa’s Smarter STIP service helps us substantially improve transaction approval rates. This is a great outcome, cleverly bringing together AI with our historical authorisation learnings, new datasets, and Visa’s experience in transaction processing to provide a rich customer experience, all the time.”
About Smarter STIP
Visa created the Smarter STIP capability to address a key pain point for issuers and issuer processors: the suboptimal experience for cardholders during service disruptions. Visa’s novel approach to stand-in processing, recognized through a US Patent in 2019, improves on the existing STIP capability through real-time evaluation of cardholder-level features. The model relies on:
- Multiple recurrent neural network layers with millions of parameters.
- Billions of historical records to train the model, resulting in an average 95% accuracy in emulating an issuer’s likely decision in Visa’s sample tests2 .
- Continuous learning from real time transaction and outage data, allowing the service to adapt and improve as an Issuers’ behavior changes over time.
Visa Smarter STIP does not require any technical change for clients to participate. Issuers connected to Visa DPS will be enabled for Smarter STIP when the service launches globally in October 2020.
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa , visa.com/blog and @VisaNews .
1
Based on Visa internal analysis comparing existing and Smarter STIP approval rates of all transactions in Q1 CY2020 for a single US Issuer.
2
This number was measured by Visa’s internal simulation of the Smarter STIP model offline on transactions for all Visa BINs globally in Q4 2019. On average, the Smarter STIP model made the same approve/decline decision as the issuers 95% of the time, for transactions across all regions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200826005289/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
